Eric M. Gordon

7.0k total citations · 2 hit papers
96 papers, 5.6k citations indexed

About

Eric M. Gordon is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Eric M. Gordon has authored 96 papers receiving a total of 5.6k indexed citations (citations by other indexed papers that have themselves been cited), including 66 papers in Molecular Biology, 46 papers in Organic Chemistry and 16 papers in Oncology. Recurrent topics in Eric M. Gordon's work include Chemical Synthesis and Analysis (38 papers), Click Chemistry and Applications (13 papers) and Plant biochemistry and biosynthesis (10 papers). Eric M. Gordon is often cited by papers focused on Chemical Synthesis and Analysis (38 papers), Click Chemistry and Applications (13 papers) and Plant biochemistry and biosynthesis (10 papers). Eric M. Gordon collaborates with scholars based in United States, Sweden and Germany. Eric M. Gordon's co-authors include Mark A. Gallop, Stephen P. A. Fodor, Ronald W. Barrett, William J. Dower, Dinesh V. Patel, M. F. GORDEEV, Daniel A. Erlanson, John R. Schullek, James F. Kerwin and Jelka Pluščec and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Journal of Biological Chemistry.

In The Last Decade

Eric M. Gordon

95 papers receiving 4.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Applications of Combinatorial Technologies to Drug Discovery. 2. Combinatorial Organic Synthesis, Library Screening Strategies, and Future Directions

1994 967 citations Eric M. Gordon, Ronald W. Barrett et al. Journal of Medicinal Chemistry profile →
Applications of Combinatorial Technologies to Drug Discovery. 1. Background and Peptide Combinatorial Libraries

1994 952 citations Mark A. Gallop, Ronald W. Barrett et al. Journal of Medicinal Chemistry profile →

Peers

Countries citing papers authored by Eric M. Gordon

Since Specialization

Citations

This map shows the geographic impact of Eric M. Gordon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric M. Gordon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric M. Gordon more than expected).

Fields of papers citing papers by Eric M. Gordon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eric M. Gordon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric M. Gordon. The network helps show where Eric M. Gordon may publish in the future.

Co-authorship network of co-authors of Eric M. Gordon

This figure shows the co-authorship network connecting the top 25 collaborators of Eric M. Gordon. A scholar is included among the top collaborators of Eric M. Gordon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eric M. Gordon. Eric M. Gordon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Prospects for Antibacterial Discovery and Development 2021 ·Journal of the American Chemical Society ·(unknown), (unknown), Jinhua Wang, Christopher T. Walsh, Gerard D. Wright, Eric M. Gordon, Nathanael S. Gray, Chaitan Khosla	66
2	In situ assembly of enzyme inhibitors using extended tethering 2003 ·Nature Biotechnology ·Daniel A. Erlanson, Joni W. Lam, Christian Wiesmann, Tinh N. Luong, Robert L. Simmons, Warren L. DeLano, Ingrid Choong, Matthew Burdett, W. Michael Flanagan, Dennis Lee, Eric M. Gordon, Thomas O’Brien	155
3	Identification of potent and novel small-Molecule inhibitors of caspase-3 2003 ·Bioorganic & Medicinal Chemistry Letters ·Darin A. Allen, (unknown), Ingrid Choong, Bruce J. Fahr, Matthew Burdett, Willard Lew, Warren L. DeLano, Eric M. Gordon, Joni W. Lam, Thomas O’Brien, Dennis Lee	18
4	Combinatorial modification of natural products: synthesis and in vitro analysis of derivatives of thiazole peptide antibiotic GE2270 A: A-ring modifications 2003 ·Bioorganic & Medicinal Chemistry Letters ·(unknown), (unknown), Eric M. Gordon, C J Hackbarth, (unknown), Joaquim Trias, Richard White, Gianpaolo Candiani, Stefano Donadio, Gabriella Romanò, Romeo Ciabatti, Jeffrey Jacobs	44
5	Combinatorial chemistry and molecular diversity in drug discovery 1998 ·Wiley eBooks ·Eric M. Gordon, James F. Kerwin	108
6	Combinatorial synthesis and screening of a chemical library of 1,4-dihydropyridine calcium channel blockers 1998 ·Bioorganic & Medicinal Chemistry ·M. F. GORDEEV, Dinesh V. Patel, B.P. England, (unknown), (unknown), Eric M. Gordon	39
7	Combinatorial modification of natural products: Preparation of unencoded and encoded libraries of Rauwolfia alkaloids 1996 ·Bioorganic & Medicinal Chemistry ·(unknown), Derek Maclean, (unknown), Eric M. Gordon, Jeffrey Jacobs	36
8	Solid-Supported Combinatorial Synthesis of Structurally Diverse β-Lactams 1996 ·Journal of the American Chemical Society ·Béatrice Ruhland, Ashok Bhandari, Eric M. Gordon, Mark A. Gallop	116
9	Phosphinyl Acid-Based Bisubstrate Analog Inhibitors of Farnesyl Protein Transferase 1995 ·Journal of Medicinal Chemistry ·Dinesh V. Patel, Eric M. Gordon, Robert J. Schmidt, Harold N. Weller, Mairead Young, Robert Zahler, Mariano Barbacid, Joan M. Carboni, Johnni Gullo-Brown, Lisa Hunihan, (unknown), (unknown), (unknown), (unknown), (unknown)	60
10	Farnesyl Diphosphate-Based Inhibitors of Ras Farnesyl Protein Transferase 1995 ·Journal of Medicinal Chemistry ·Dinesh V. Patel, Robert J. Schmidt, Scott A. Biller, Eric M. Gordon, Simon Robinson, Veeraswamy Manne	57
11	Applications of Combinatorial Technologies to Drug Discovery. 1. Background and Peptide Combinatorial Libraries breakdown → 1994 ·Journal of Medicinal Chemistry ·Mark A. Gallop, Ronald W. Barrett, William J. Dower, Stephen P. A. Fodor, Eric M. Gordon	952
12	Amino Diol HIV Protease Inhibitors. 1. Design, Synthesis, and Preliminary SAR 1994 ·Journal of Medicinal Chemistry ·Joel C. Barrish, Eric M. Gordon, Masud Alam, P F Lin, Gregory S. Bisacchi, Pei‐Shih Chen, (unknown), A. W. FRITZ, (unknown)	57
13	The first potent inhibitor of squalene synthase: a profound contribution of an ether oxygen to inhibitor-enzyme interaction 1991 ·Journal of the American Chemical Society ·Scott A. Biller, Michael J. Sofia, (unknown), Cornelia J. Forster, Eric M. Gordon, Thomas Harrity, (unknown), Carl P. Ciosek	62
14	Isoprenyl phosphinylformates: new inhibitors of squalene synthetase 1991 ·Journal of Medicinal Chemistry ·Scott A. Biller, Carola Y. Förster, Eric M. Gordon, Thomas Harrity, (unknown), (unknown), Carl P. Ciosek	46
15	Phosphorus-containing inhibitors of HMG-CoA reductase. I. 4-[(2-Arylethyl)hydroxyphosphinyl]-3-hydroxybutanoic acids: a new class of cell selective inhibitors of cholesterol biosynthesis 1990 ·Journal of Medicinal Chemistry ·Donald S. Karanewsky, Michael C. Badia, Carl P. Ciosek, Jeffrey A. Robl, Michael J. Sofia, Ligaya M. Simpkins, (unknown), Thomas Harrity, Scott A. Biller, Eric M. Gordon	42
16	Isoprenoid (phosphinylmethyl)phosphonates as inhibitors of squalene synthetase 1988 ·Journal of Medicinal Chemistry ·Scott A. Biller, Cornelia J. Forster, Eric M. Gordon, Thomas Harrity, William Scott, Carl P. Ciosek	69
17	Ketomethylureas. A New Class of Angiotensin Converting Enzyme Inhibitors 1988 ·Journal of enzyme inhibition ·(unknown), Eric M. Gordon, Emily F. Sabo, Jollie D. Godfrey, Harold N. Weller, Jelka Pluščec, (unknown), (unknown), David W. Cushman, Jack M. DeForrest, James Powell	2
18	Rational Design and Biochemical Utility of Specific Inhibitors of Angiotensin-Converting Enzyme 1987 ·Journal of Cardiovascular Pharmacology ·David W. Cushman, Miguel A. Ondetti, Eric M. Gordon, (unknown), Donald S. Karanewsky, John Krapcho, Edward W. Petrillo	37
19	Purification and characterization of enkephalinase, angiotensin converting enzyme, and a third peptidyldipeptidase from rat brain 1983 ·Life Sciences ·David W. Cushman, Eric M. Gordon, (unknown), H.S. Cheung, Roger D. Tung, Norma G. Delaney	12
20	On the transformation of penicillins to 3-methyl or 3-methylene cephams 1977 ·Tetrahedron Letters ·Eric M. Gordon, C. M. CIMARUSTI	7

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact